closed the week at ₹837.85 on September 25, 2026, down about 4.25% for the week, a notable underperformance against the Sensex, which fell just 0.76% over the same period. 1)The week started on a strong note before reversing hard. Monday saw the stock open at ₹897.00, up 2.51% from the prior Friday's close, with robust volume signaling investor interest. That early strength faded as selling pressure built through the rest of the week. 2)Technical momentum turned bearish mid-week. By Tuesday, weekly and monthly MACD and KST oscillators had shifted from sideways to mildly bearish, even as broader markets stayed roughly flat. 3)Derivatives activity flagged rising caution. Open interest jumped 24.6% on Thursday and surged further on Friday as the stock declined sharply that day, a sign of growing speculative positioning and market unease rather than routine profit-booking. 4)There was genuine positive news earlier in September. On September 17, Fortis rose 2.5% on a 29-year healthcare services partnership announcement, and the stock carries a "Buy" consensus from 17 analysts with a median target of ₹1,100, well above current levels. 5)Q1 fundamentals were actually strong. Consolidated net profit rose 53.3% YoY, with revenue up 16.6% YoY, solid underlying business performance that hasn't translated into recent stock price strength. 6)The stock's market cap now stands at roughly ₹66,236 crore, with the 52-week range sitting between ₹767.30 and ₹1,105, so despite this week's decline, it remains well above its yearly low.

#FundamentalViews#TechnicalViews